Ardelyx, Inc. - 54 Year Dividend History | ARDX
Historical dividend payout and yield for Ardelyx, Inc. (ARDX) since 1971. The current TTM dividend payout for Ardelyx, Inc. (ARDX) as of February 21, 2025 is $0.00. The current dividend yield for Ardelyx, Inc. as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$1.198B |
$0.334B |
|
Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase II clinical trials for the treatment of patients with ESRD-HD and chronic kidney disease, as well as for constipation-predominant irritable bowel syndrome. Ardelyx, Inc. is headquartered in Fremont, California.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
